Question follow-through · 64594
Brain: Tumours
To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) the Medicines and Healthcare products Regulatory Agency and (b) the National institute for Health and Care Excellence on access to innovative treatment for pati
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 2 Jul 2025
- Target answer date
- 4 Jul 2025
- Answer
- 10 Jul 2025 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Brain Cancer · 10 Oct 2025
- Brain Cancer: Research · 10 Oct 2025
- Brain: Tumours · 10 Oct 2025
- Brain: Tumours · 10 Oct 2025
- Brain Cancer: Research · 10 Oct 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
2 Jul 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) the Medicines and Healthcare products Regulatory Agency and (b) the National institute for Health and Care Excellence on access to innovative treatment for pati
4 Jul 2025
Target answer date
Date supplied by the official written-questions record.
10 Jul 2025
Answer published
The Department is committed to ensuring that all patients, including those with brain tumours, have access to cutting-edge clinical trials and innovative, lifesaving treatments. As such, officials meet regularly with the Medicines and Healthcare products ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Brain Cancer
10 Oct 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to include astrocytoma brain cancer in the (a) National Cancer Plan, (b) Rare Cancers Bill and (c) NHS Cancer Vaccine Launch Pad.
Brain Cancer: Research
10 Oct 2025 · To ask the Secretary of State for Health and Social Care, how much and what percentage of total research expenditure has been spent on research into (a) Giloma, (b) Glioblastoma, (c) Astrocytoma, (d) DIPG and (e) DMG brain tumour types in the last decade.
Brain: Tumours
10 Oct 2025 · To ask the Secretary of State for Health and Social Care, how much funding his Department has provided for brain tumour research in each year since 2018.
Brain: Tumours
10 Oct 2025 · To ask the Secretary of State for Health and Social Care, whether he has considered using brain tumour research funding announced in 2018 to fund an increase in the speed of research into new treatments.
Brain Cancer: Research
10 Oct 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking with Cancer Research UK to increase levels of future funding for brain tumour research.
Brain: Tumours
10 Oct 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of using brain tumour research funding announced in 2018 for supporting (a) new vaccines and (b) novel therapeutics.
Health Hazards: Birmingham
27 Nov 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 April 2025 to Question 44226 on Pest Control: Birmingham, whether he has made a recent assessment of the risks to (a) public health from the continued bin strike and (b
Dementia: Health Services
30 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he will ensure that the forthcoming Modern Service Framework for Frailty and Dementia includes a standardised and proactive post-diagnostic support offer for people living with dementia.